Table I.
The classification results obtained by comparing the MSP in rapport with each other.
| Individual MSP score
|
Group MSP score
|
||
|---|---|---|---|
| Cell line | Score | Cell group/type | Score |
| A375 | |||
| A375 | 3 | Human melanoma | 3 |
| MDA-MB-231 | 1.832 | Human carcinoma | 2.27 |
| B164A5 | 1.405 | Murine melanoma | 0.641 |
| HepG2 | 1.397 | ||
| B16-F0 | 1.389 | ||
| MCF7 | 1.344 | ||
| HepG2 | |||
| HepG2 | 3 | Human carcinoma | 2.505 |
| MDA-MB-231 | 2.451 | Human melanoma | 1.397 |
| MCF7 | 2.109 | Murine melanoma | 1.35 |
| A375 | 1.397 | ||
| B16-F0 | 1.386 | ||
| B164A5 | 1.003 | ||
| B16-F0 | |||
| B16-F0 | 3 | Murine melanoma | 2.782 |
| B164A5 | 2.479 | Human carcinoma | 1.406 |
| HepG2 | 1.498 | Human melanoma | 1.389 |
| A375 | 1.389 | ||
| MDA-MB-231 | 1.329 | ||
| MCF7 | 1.304 | ||
| B164A5 | |||
| B164A5 | 3 | Murine melanoma | 2.659 |
| B16-F0 | 2.48 | Human melanoma | 1.405 |
| A375 | 1.405 | Human carcinoma | <0 |
| MCF7 | 1.354 | ||
| HepG2 | 1.003 | ||
| MDA-MB-231 | 0.641 | ||
| MCF7 | |||
| MCF7 | 3 | Human carcinoma | 2.116 |
| HepG2 | 2.109 | Human melanoma | 1.344 |
| MDA-MB-231 | 1.464 | Murine melanoma | 1.331 |
| B164A5 | 1.354 | ||
| A375 | 1.344 | ||
| B16-F0 | 1.304 | ||
| MDA-MB-231 | |||
| MDA-MB-231 | 3 | Human carcinoma | 2.443 |
| HepG2 | 2.449 | Human melanoma | 1.832 |
| A375 | 1.832 | Murine melanoma | 0.574 |
| MCF7 | 1.466 | ||
| B164A5 | 1.393 | ||
| B16-F0 | 1.343 | ||
The maximum score is 3. The higher the scores, the higher the relationship. MSP, main spectrum.